pyro-Glu-Phe-Lys-pNA,
S 2403,
S-2403,
S2403,
6-Amino-5-bromoquinoxaline,
50358-63-9,
5-BROMOQUINOXALIN-6-AMINE,
5-bromo-6-quinoxalinamine,
6-Quinoxalinamine, 5-bromo-,
5-bromoquinoxaline-6-ylamine,
MFCD00799024,
PubChem15452,
5-Bromo-6-aminoquinoxaline,
6-Quinoxalinamine,5-bromo-,
6-amino-5-bromo quinoxaline,
KSC592K1D,
ARONIS24444,
SCHEMBL180196,
CTK4J2511,
IRAOSCSPAYZRJE-UHFFFAOYSA-N,
KS-000048IK,
AC-193,
ANW-49470,
BBL023036,
CA-427,
SBB054605,
STL356016,
ZINC16123529,
AKOS015854599,
ACN-034835,
AN-6803,
CM14407,
CS-W022443,
LS40346,
MCULE-7919170768,
RP27506,
TRA0035106,
KS-000009Z3,
134892-45-8,
AJ-68222,
AK-28584,
BC004009,
BC215785,
BR-28584,
CJ-15300,
SC-18572,
SY030906,
TS-03199,
6-AMINOCHINOXALIN-5-BROMCHINOXALINE,
AB0010497,
ST2412172,
TL8003338,
TR-018001,
FT-0620934,
FT-0650286,
MFCD00799024 (97%),
S-2403,
358A639,
Q-100562,
Brimonidine Related Compound (5-Bromo-6-Aminoquinoxaline),
Not Available,
C8H6BrN3,
6-quinoxalinamina, 5-bromo-,
C8 H6 Br N3,
6-Amino-5-bromoquinoxaline, 98% 1g,
CS-O-31997,
A2913,
A7472,
6-Amino-5-bromoquinoxaline, 98% - 1G 1g,